Bvf Investments LLC
Bvf Investments LLC
Bvf Investments LLC insider trades: Capstone Therapeutics (CAPS) stock buys and sales
Capstone Therapeutics Last trade Jul 14, 2017 126 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
142
Open-market trades
since 2006
23
Companies
last trade 2017
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bvf Investments LLC reports to the SEC
CAPSCapstone Therapeutics
Insider · last filing Jul 18, 2017
-$260K
+$526K
CCXIChemoCentryx
Insider · last filing Nov 5, 2015
-$11.5M
+$13.2M
LGNDLigand Pharmaceuticals
Insider · last filing Mar 26, 2014
-$97.4M
+$22.6M
PTNPalatin Technologies
Insider · last filing Mar 3, 2014
-$1.3M
RIGLRigel Pharmaceuticals
Insider · last filing Nov 20, 2013
-$1.3M
+$113K
TRGTTargacept
Insider · last filing Nov 19, 2012
-$15.1M
+$5.3M
and 17 more companies
Open-market buys and sales
142 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 14, 2017 | CAPS | ↓ Sell | 3,993,637 | $0.06 | $240K | By BVF Investments, L.L.C. | Jul 18, 2017 (4d) |
| Jul 14, 2017 | CAPS | ↓ Sell | 242,236 | $0.06 | $15K | By Biotechnology Value Fund, L.P. | Jul 18, 2017 (4d) |
| Jul 14, 2017 | CAPS | ↓ Sell | 105,713 | $0.06 | $6K | By Biotechnology Value Fund II, L.P. | Jul 18, 2017 (4d) |
| Nov 4, 2015 | CCXI | ↓ Sell | 360,000 | $7.00 | $2.5M | See Explanation of Reponses | Nov 5, 2015 (1d) |
| Nov 2, 2015 | CCXI | ↓ Sell | 50,000 | $6.97 | $349K | See Explanation of Reponses | Nov 2, 2015 (0d) |
| Jun 10, 2015 | CCXI | ↓ Sell | 955,700 | $9.00 | $8.6M | See Explanation of Reponses | Jun 11, 2015 (1d) |
| Mar 25, 2014 | LGND | ↓ Sell | 49,717 | $70.09 | $3.5M | By Biotechnology Value Fund, L.P. | Mar 26, 2014 (1d) |
| Mar 25, 2014 | LGND | ↓ Sell | 28,509 | $70.09 | $2.0M | By Biotechnology Value Fund II, L.P. | Mar 26, 2014 (1d) |
| Feb 27, 2014 | PTN | ↓ Sell | 200,827 | $1.09 | $219K | By BVF Investments, L.L.C. | Mar 3, 2014 (4d) |
| Feb 27, 2014 | PTN | ↓ Sell | 59,388 | $1.09 | $65K | By Biotechnology Value Fund, L.P. | Mar 3, 2014 (4d) |
| Feb 27, 2014 | PTN | ↓ Sell | 33,610 | $1.09 | $37K | By Biotechnology Value Fund II, L.P. | Mar 3, 2014 (4d) |
| Feb 26, 2014 | PTN | ↓ Sell | 376,575 | $1.14 | $429K | By BVF Investments, L.L.C. | Feb 26, 2014 (0d) |
| Feb 26, 2014 | PTN | ↓ Sell | 104,420 | $1.14 | $119K | By Biotechnology Value Fund, L.P. | Feb 26, 2014 (0d) |
| Feb 26, 2014 | PTN | ↓ Sell | 59,186 | $1.14 | $67K | By Biotechnology Value Fund II, L.P. | Feb 26, 2014 (0d) |
| Feb 20, 2014 | LGND | ↓ Sell | 323,490 | $73.81 | $23.9M | By BVF Investments, L.L.C. | Feb 20, 2014 (0d) |
| Feb 20, 2014 | LGND | ↓ Sell | 44,994 | $73.65 | $3.3M | By Biotechnology Value Fund, L.P. | Feb 20, 2014 (0d) |
| Feb 20, 2014 | LGND | ↓ Sell | 32,283 | $73.86 | $2.4M | By Biotechnology Value Fund II, L.P. | Feb 20, 2014 (0d) |
| Feb 20, 2014 | LGND | ↓ Sell | 22,133 | $74.06 | $1.6M | By Investment 10, L.L.C. | Feb 20, 2014 (0d) |
| Feb 19, 2014 | PTN | ↓ Sell | 149,912 | $1.17 | $175K | By Biotechnology Value Fund, L.P. | Feb 19, 2014 (0d) |
| Feb 19, 2014 | PTN | ↓ Sell | 136,977 | $1.17 | $160K | By Biotechnology Value Fund II, L.P. | Feb 19, 2014 (0d) |
| Feb 19, 2014 | PTN | ↓ Sell | 19,077 | $1.11 | $21K | By BVF Investments, L.L.C. | Feb 19, 2014 (0d) |
| Dec 5, 2013 | CCXI | ↑ Buy | 189,800 | $5.01 | $951K | See Explanation of Responses | Dec 5, 2013 (0d) |
| Nov 27, 2013 | LGND | ↓ Sell | 527,505 | $57.27 | $30.2M | See Explanation of Responses | Nov 29, 2013 (2d) |
| Nov 19, 2013 | RIGL | ↓ Sell | 484,622 | $2.64 | $1.3M | See Explanation of Responses | Nov 20, 2013 (1d) |
| Nov 6, 2013 | CCXI | ↑ Buy | 136,066 | $4.92 | $670K | See Explanation of Responses | Nov 6, 2013 (0d) |
| Nov 1, 2013 | CCXI | ↑ Buy | 336,225 | $4.99 | $1.7M | See Explanation of Responses | Nov 1, 2013 (0d) |
| Oct 9, 2013 | CCXI | ↑ Buy | 1,289,354 | $5.34 | $6.9M | See Explanation of Responses | Oct 10, 2013 (1d) |
| Oct 3, 2013 | CCXI | ↑ Buy | 109,425 | $5.49 | $601K | See Explanation of Responses | Oct 7, 2013 (4d) |
| Sep 23, 2013 | LGND | ↓ Sell | 359,023 | $44.50 | $16.0M | See Explanation of Responses | Sep 25, 2013 (2d) |
| Sep 13, 2013 | CCXI | ↑ Buy | 325,635 | $5.95 | $1.9M | See Explanation of Responses | Sep 13, 2013 (0d) |
| Jun 7, 2013 | RIGL | ↑ Buy | 32,700 | $3.47 | $113K | See Explanation of Responses | Jun 11, 2013 (4d) |
| Jan 23, 2013 | LGND | ↑ Buy | 39,600 | $19.78 | $783K | See Explanation of Responses | Jan 25, 2013 (2d) |
| Dec 14, 2012 | LGND | ↑ Buy | 5,386 | $18.63 | $100K | See Explanation of Responses | Dec 18, 2012 (4d) |
| Dec 6, 2012 | LGND | ↑ Buy | 50,100 | $17.94 | $899K | See Explanation of Responses | Dec 10, 2012 (4d) |
| Nov 16, 2012 | TRGT | ↑ Buy | 1,290,212 | $4.06 | $5.2M | See Explanation of Responses | Nov 19, 2012 (3d) |
| Nov 6, 2012 | CCXI | ↑ Buy | 40,000 | $12.00 | $480K | See Explanation of Responses | Nov 8, 2012 (2d) |
| Dec 5, 2011 | ARRY | ↑ Buy | 174,653 | $2.12 | $370K | See Explanation of Responses | Dec 5, 2011 (0d) |
| Dec 1, 2011 | ARRY | ↑ Buy | 9,200 | $2.04 | $19K | See Explanation of Respones | Dec 5, 2011 (4d) |
| Nov 21, 2011 | LGND | ↑ Buy | 412,869 | $10.66 | $4.4M | See Explanation of Responses | Nov 22, 2011 (1d) |
| Nov 21, 2011 | LGND | ↑ Buy | 98,171 | $10.59 | $1.0M | See Explanation of Respones | Nov 22, 2011 (1d) |
| Oct 26, 2011 | LGND | ↑ Buy | 6,020 | $13.91 | $84K | See Explanation of Responses | Oct 28, 2011 (2d) |
| Oct 21, 2011 | LGND | ↑ Buy | 4,600 | $13.93 | $64K | See Explanation of Responses | Oct 25, 2011 (4d) |
| Oct 20, 2011 | LGND | ↑ Buy | 14,100 | $13.90 | $196K | See Explanation of Responses | Oct 20, 2011 (0d) |
| Oct 13, 2011 | LGND | ↑ Buy | 70,358 | $13.66 | $961K | See Explanation of Responses | Oct 14, 2011 (1d) |
| Oct 13, 2011 | LGND | ↑ Buy | 4,995 | $13.55 | $68K | See Explanation of Respones | Oct 14, 2011 (1d) |
| Oct 12, 2011 | NBIX | ↑ Buy | 29,500 | $5.96 | $176K | See Explanation of Responses | Oct 14, 2011 (2d) |
| Oct 11, 2011 | NBIX | ↑ Buy | 48,500 | $5.60 | $272K | By BVF Investments, L.L.C. | Oct 12, 2011 (1d) |
| Oct 10, 2011 | NBIX | ↑ Buy | 15,800 | $5.59 | $88K | By Biotechnology Value Fund, L.P. | Oct 12, 2011 (2d) |
| Oct 10, 2011 | NBIX | ↑ Buy | 9,600 | $5.59 | $54K | By Biotechnology Value Fund II, L.P. | Oct 12, 2011 (2d) |
| Oct 4, 2011 | LGND | ↑ Buy | 14,400 | $12.78 | $184K | See Explanation of Responses | Oct 6, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bvf Investments LLC's insider trades
Bvf Investments LLC is an insider at Capstone Therapeutics (CAPS). Since Jan 13, 2006, it has reported 89 open-market purchases worth $139.0M and 53 sales worth $205.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CAPS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.